1. Home
  2. ANIX vs MCHX Comparison

ANIX vs MCHX Comparison

Compare ANIX & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • MCHX
  • Stock Information
  • Founded
  • ANIX 1982
  • MCHX 2003
  • Country
  • ANIX United States
  • MCHX United States
  • Employees
  • ANIX N/A
  • MCHX N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • ANIX Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • ANIX Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • ANIX 91.7M
  • MCHX 79.9M
  • IPO Year
  • ANIX 1987
  • MCHX 2004
  • Fundamental
  • Price
  • ANIX $2.53
  • MCHX $1.98
  • Analyst Decision
  • ANIX Strong Buy
  • MCHX
  • Analyst Count
  • ANIX 2
  • MCHX 0
  • Target Price
  • ANIX $8.50
  • MCHX N/A
  • AVG Volume (30 Days)
  • ANIX 102.1K
  • MCHX 107.2K
  • Earning Date
  • ANIX 01-14-2025
  • MCHX 10-31-2024
  • Dividend Yield
  • ANIX N/A
  • MCHX N/A
  • EPS Growth
  • ANIX N/A
  • MCHX N/A
  • EPS
  • ANIX N/A
  • MCHX N/A
  • Revenue
  • ANIX N/A
  • MCHX $48,594,000.00
  • Revenue This Year
  • ANIX N/A
  • MCHX N/A
  • Revenue Next Year
  • ANIX N/A
  • MCHX $4.63
  • P/E Ratio
  • ANIX N/A
  • MCHX N/A
  • Revenue Growth
  • ANIX N/A
  • MCHX N/A
  • 52 Week Low
  • ANIX $2.15
  • MCHX $1.11
  • 52 Week High
  • ANIX $5.13
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 26.19
  • MCHX 63.40
  • Support Level
  • ANIX $2.80
  • MCHX $1.98
  • Resistance Level
  • ANIX $3.43
  • MCHX $2.40
  • Average True Range (ATR)
  • ANIX 0.20
  • MCHX 0.15
  • MACD
  • ANIX -0.06
  • MCHX 0.02
  • Stochastic Oscillator
  • ANIX 1.10
  • MCHX 59.23

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: